MedTrace Logo

The Effect of Nurse Practitioner Led-Care on Quality of Life in Patients With Atrial Fibrillation

NCT02745236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2021-04-28

No results posted yet for this study

Summary

Atrial fibrillation (AF) is the most common heart rhythm disease characterized by an irregular heart rhythm of the top part (atria) of the heart. It may cause unpleasant symptoms as well as increases the person's risk of stroke and heart failure. With an ageing population, increasing rates of AF and limited access to specialists, new methods of care, like nurse practitioners (NP) need to be assessed to meet patient specific needs and provide sustainable care.

The objective of the project is to evaluate the effect of Nurse Practitioner-led care in people with AF on their quality of life.

The Canadian Healthcare system is overwhelmed, with increasing costs and wait times. Contributing to these issues, is AF is the most common arrhythmia accompanied with costly complications including stroke and heart failure. Currently family or emergency room physicians ask general cardiologists or specialized cardiologists, to provide care to patients with AF. Unfortunately, there is limited access to their services. NP's are nurses who have taken extra education at University to treat patients and prescribe medications. This research project involves an NP who has specialized training in AF patient management.

By utilizing an NP to provide care for patients with AF, the investigators hope to improve patient's quality of life and satisfaction with care. This may also reduce complications of AF.

Conditions

Interventions

OTHER

Nurse Practitioner Led-Care

Diagnosis and treatment plan decisions will be determined by Nurse Practitioner Led-Care.

OTHER

Cardiologist Led-Care

Diagnosis and treatment plan decisions will be determined as per usual care by the Cardiologist

Sponsors & Collaborators

  • University Hospital Foundation

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Marcie J Smigorowsky, PhD, NP · University of Alberta

  • Ross T Tsuyuki, PharmD, MSc · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2020-09-01
Completion
2020-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02745236 on ClinicalTrials.gov